Status:
COMPLETED
Mindfullnes-Based Cognitive Therapy Effect
Lead Sponsor:
SEMRA BÜLBÜLOĞLU
Conditions:
Mindfullnes-Based Cognitive Therapy and Adherence to Immunosuppressive Therapy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Objective: In this study, the effect of mindfulness-based cognitive therapy on compliance with immunosuppressive therapy in liver transplant patients was evaluated. Method: It was conducted the study ...
Detailed Description
It was used simple random sampling method in assigning liver recipients to the experimental and control groups. Discharged liver transplant patients are informed about the use of immunosuppressive dru...
Eligibility Criteria
Inclusion
- Inclusion Criteria involved (i) being a liver transplant recipient, (ii) currently having immunosuppressive treatment, (iii) being 18 years or older (iv) having no language or communication barrier and (v) agreeing to participate in the study.
- Liver transplant recipients
Exclusion
- The exact opposite of the inclusion criteria the exclusion criteria.
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2023
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT05995938
Start Date
August 1 2022
End Date
January 30 2023
Last Update
August 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the Liver Transplant Hospital affiliated with Turgut Özal Medical Center of İnönü University of Malatya/Turkey.
Malatya, Turkey (Türkiye)